Long-Term Observation of a Man With Severe Obesity and Undiagnosed Monogenic Diabetes Serendipitously Treated With Metabolic Surgery

Autor: Su Chi Lim, Bhuvaneswari Pandian, Su Fen Ang, Clara Si Hua Tan, Anton Cheng, Chee Fang Sum, Mei Chung Moh, Wanxin Lai, Boon Khim Lim, Tavintharan Subramaniam, Chun Hai Tan
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Adult
Male
Heterozygote
medicine.medical_specialty
Sleeve gastrectomy
Epidemiology
medicine.medical_treatment
Gastric Bypass
Case Report
030209 endocrinology & metabolism
Type 2 diabetes
Hypoglycemia
Gastroenterology
Germinal Center Kinases
whole exome sequencing
03 medical and health sciences
0302 clinical medicine
Gastrectomy
metabolic surgery
Internal medicine
Diabetes mellitus
Exome Sequencing
medicine
lcsh:Pathology
Humans
Safety
Risk
Reliability and Quality

Exome sequencing
030304 developmental biology
Glycated Hemoglobin
glucokinase
0303 health sciences
lcsh:R5-920
Glucokinase
business.industry
Metabolic surgery
nutritional and metabolic diseases
medicine.disease
Obesity
Morbid

Treatment Outcome
Diabetes Mellitus
Type 2

Hyperglycemia
Concomitant
monogenic diabetes
type 2 diabetes
business
lcsh:Medicine (General)
Safety Research
lcsh:RB1-214
Zdroj: Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Journal of Investigative Medicine High Impact Case Reports
ISSN: 2324-7096
Popis: A 43-year-old man, with severe obesity (43 kg/m2) and diabetes (presumed as type 2 diabetes [T2D]), underwent vertical sleeve gastrectomy in 2009 and Roux-en-Y gastric bypass in 2013. Recently, whole exome sequencing (conducted to search for monogenic obesity) serendipitously revealed that the individual harbored a heterozygous glucokinase ( GCK) variant p.(Arg422Leu) that was bioinformatically strongly predicted to be likely pathogenic. Therefore, he is likely to have concomitant maturity-onset diabetes of the young (MODY) type 2 ( GCK-MODY). A retrospective evaluation of the clinical data showed that the subject was diagnosed with T2D (given his severe obesity) in 2005 and was treated with oral antidiabetic monotherapy. His hyperglycemia was mostly mild (HbA1c [hemoglobin] < 8.1%), consistent with that of MODY2, despite severe obesity. After vertical sleeve gastrectomy, complete diabetes remission (HbA1c
Databáze: OpenAIRE